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11 Abstract As an example of the cost-effective large-scale
12 generation of small-interfering RNA (siRNAs), we have created
13 transgenic tobacco plants that produce siRNAs targeted to the
14 mRNA of the non-structural protein NS1 from the influenza A
15 virus subtype H1N1. We have investigated if these siRNAs,
16 specifically targeted to the 50-portion of the NS1 transcripts
17 (5mNS1), would suppress viral propagation in mammalian cells.
18 Agroinfiltration of transgenic tobacco with an Agrobacterium
19 strain harboring a 5mNS1-expressing binary vector caused a
20 reduction in 5mNS1 transcripts in the siRNA-accumulating
21 transgenic plants. Further, H1N1 infection of siRNA-transfected
22 mammalian cells resulted in significant suppression of viral
23 replication. These results demonstrate that plant-derived siRNAs
24 can inhibit viral propagation through RNA interference and
25 could potentially be applied in control of viral-borne diseases.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
Keywords: Transgenic plant; Small-interfering RNA; Gene
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32 1. Introduction
33 RNA interference (RNAi) is an ancient and evolutionarily
34 conserved activity in eukaryotes. It results in RNA-mediated
35 RNA degradation in a sequence-specific manner. Originally
36 described in plants as a concerted inactivation of host genes
37 and transgenes transcribing the same or similar sequences [1],
38 it has been confirmed to occur in many different organisms.
39 Examples include quelling in Neurospora crassa [2], and RNAi
40 in Caenorhabditis elegans [3], Drosophila [4] and mammals [5].
41 In all these cases, RNAi is achieved through several closely
42 coordinated steps: (1) an endonuclease Dicer with RNase III
43 activity cleaves the dsRNA into 21–23 bp small interfering
44 RNAs (siRNAs); (2) the siRNAs interact with a multicom-
45ponent nuclease to form an RNA-induced silencing complex
46(RISC); (3) the siRNA in the RISC directs the complex to the
47target RNA through sequence complementarity; (4) RNA
48polymerization begins from the siRNA to form dsRNA; and
49(5) the dsRNA is cleaved into siRNAs [6,7]. The resulting
50siRNAs would then initiate another round of RNA cleavage.
51Studies using synthetic [8], in vitro transcribed [9,10] and in
52vivo transcribed [11,12] siRNAs, as well as viral-mediated
53siRNA delivery [13], have demonstrated that well-designed
54siRNAs can effectively suppress target gene expression. Hence,
55RNAi technology could eventually be applied in the thera-
56peutics of human and animal viral diseases of which the mo-
57lecular components, e.g., viral sequences, are known, and in
58the case of infectious diseases, of which the relevant pathogens
59have been identified. In plants, viral-resistance has already
60been achieved through a plant RNAi pathway termed post-
61trancriptional gene silencing (PTGS) [14].
62Although some understanding on siRNA inhibition of viral
63propagation [8,11] has been achieved, the local folding of the
64target RNAs that reduces siRNA accessibility within a tran-
65script [15] makes it necessary to test out many different siR-
66NAs before optimal transcript degradation can be attained
67[8,16]. For example [8], 20 siRNA oligos were screened before
68identification of one that could satisfactorily suppress repli-
69cation of the influenza virus in mammalian cells. Also, siRNA-
70mediated gene suppression in mammals requires the dsRNA to
71be smaller than 30 bp to ensure specificity [17], as long dsRNA
72can provoke non-specific degradation of RNA transcripts and
73a general shutdown of protein translation [18]. Therefore, it is
74impossible to transfect mammalian cells with long-dsRNA-
75producing constructs essential for making multiple siRNAs.
76The high cost in RNA oligo synthesis and the toxic effects of
77long dsRNA in mammalian cells could be ameliorated by cost-
78effective techniques in simultaneous large-quantity production
79of different siRNAs to achieve a satisfactory level for RNAi-
80mediated gene suppression.
81Here, we demonstrate that tobacco (Nicotiana tabacum) can
82be engineered by Agrobacterium-mediated transformation to
83produce siRNAs targeting the mRNA for the non-structural
84NS1 protein of the influenza virus A/WSN/33, subtype H1N1.
85The transgenic plants could effectively accumulate siRNAs
86that specifically target gene encoding the non-structural pro-
87tein NS1 (NS1) transcripts. Transfection of mammalian cells
88with plant-derived siRNAs followed by infection of the influ-
89enza virus revealed significant reduction in viral propagation.
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90 Our data demonstrate that plants can be used as an econom-
91 ical and sustainable source for large-scale production of di-
92 versified siRNAs.
93 2. Materials and methods
94 2.1. Construction of hairpin RNA vector and generation of transgenic
95 tobacco plants
96 A 0.4-kb fragment representing the 50-portion of the NS1 mRNA
97 (5mNS1) from the influenza virus strain A/WSN/33 subtype H1N1
98 (Fig. 1A and B) was amplified by reverse-transcriptase polymerase
99 chain reaction (RT-PCR) using forward primer 50-
100 gggcggccgcggatccatggacccaaacactgtg-30 with NotI (in italics) and
101 BamHI (in bold) sites incorporated at its 50-end, and reverse primer 50-
102 caactagtatttcgctttcagtatga-30 with an added SpeI site (in italics). The
103 underlined nucleotides represent NS1 sequences. The PCR product
104 was initially cloned in pGEM-T Easy vector (Promega) for verification
105 of DNA sequence. Subsequently, the pGEM-T Easy derivative was
106 digested with either BamHI and SpeI or NotI and SpeI. The 0.4-kb
107 BamHI–SpeI 5mNS1 fragment was cloned into corresponding sites in a
108 pBluescript SKII()) derivative that contains the Arabidopsis TGA1
109 intron [19] inserted at its SpeI–XbaI site. Next, the 0.4-kb NotI–SpeI
110 5mNS1 fragment from the pGEM-T Easy derivative was cloned in the
111 NotI–XbaI site of the pBluescript SK(II)()) derivative containing the
112 DNA fusion of ‘‘sense 5mNS1-TGA1 intron’’, to generate a dsRNA
113 cassette ‘‘sense 5mNS1-TGA1 intron–antisense 5mNS1’’. This cassette
114 was then released by NotI and BamHI digestion, and, with the help of
115 a NotI/XbaI adaptor (upper strand, 50-GGCCGAGTTGTTA-30; lower
116 strand, 50-CTAGTAACAACTC-30), was cloned in the BamHI–XbaI
117 site between the CaMV 35S promoter and the nos terminator, in an-
118 other pBluescript SKII()) derivative. The resulting vector therefore
119 contains a cassette of ‘‘35S-s 5mNS1–TGA1 intron–as 5mNS1 nos’’
120 (Fig. 1C). This cassette was further digested with NotI and KpnI, and
121 was cloned into corresponding sites within the T-DNA in a pBI101
122 backbone plasmid derivative (Clontech, Palo Alto, USA). The binary
123 vector was then mobilized into Agrobacterium tumefaciens strain
124 GV3101/MP90 for transformation of tobacco cultivar Samsun NN by
125 the leaf-disk procedure [20].
126 2.2. siRNA detection
127 Total RNA samples were extracted from tobacco leaves using
128 TRIzol (Invitrogen). Twenty micrograms of total RNA was separated
129 on a 15% polyacrylamide gel containing 7 M urea and was electrob-
130 lotted onto a nitrocellulose membrane (GeneScreen Plus, PerkinEl-
131 mer Life Sciences, Inc.). The blot was then hybridized overnight at 42
132C to [32P]UTP-labeled 5mNS1 riboprobes generated using the Ri-
133boprobe in vitro Transcription Systems (Promega), in a solution of
13450% (v/v) formamide, 250 mM NaCl, 7% SDS and 125 mM phosphate
135buffer, pH 7.0. After hybridization, the blot was washed twice with 2·
136SSC plus 0.5% SDS and was then analyzed using a phospho-imager.
137The volumes of the synthetic siRNA and of the siRNA from transgenic
138plants were measured using an ImageQuant software (Molecular Dy-
139namics), and the amount of siRNA in the plant RNA sample was
140calculated based on its volume relative to that of synthetic, known
141amount of RNA oligos.
1422.3. Transient expression assay by agroinfiltration
143Agrobacterium cells containing the 5mNS1-expressing binary vector
144and those containing an EYFP-T2m (EYFP, gene encoding the en-
145hanced yellow fluorescent protein) expressing binary vector [21] were
146inoculated in an induction solution containing 1 g/l NH4Cl, 0.3 g/l
147MgSO4.7H2O, 0.15 g/l KCl, 0.01 g/l CaCl2, 0.0025 g/l FeSO4 Æ 7H2O, 2
148mM phosphate, 1% glucose, 20 mM 2-(N-morpholino)ethanesulfonic
149acid (MES, pH 5.5), 100 lM acetosyringone, 50 lg/ml kanamycin and
15050 lg/ml gentamycin. The EYFP-T2m contains EYFP fused in-frame
151to a mutant version of the Arabidopsis TGA2 gene (T2m) and is used as
152an expression reference after agroinfiltration. Following overnight
153culture at 28 C, the cells were collected by centrifugation at 3000 g
154for 15 min, and then resuspended in an infiltration solution containing
15510 mM MES (pH 5.5), 10 mM MgSO4 and 100 lM acetosyringone.
156The resuspended Agrobacterium cells were adjusted to an OD600 of 0.8
157with the same solution before infiltration of tobacco leaves using a 1 ml
158syringe. After two days, total RNA was extracted from the infiltrated
159leaf areas for Northern blot analysis.
1602.4. Northern blot analysis
161Five micrograms of total RNA, extracted from the agroinfiltrated
162and non-infiltrated leaf areas, were separated on a 1.2% agarose gel,
163blotted with 20 SSC onto a nitrocellulose membrane, and hybridized
164to [32P]dCTP-labeled DNA probes generated from 5mNS1 and EYFP
165DNA fragments using a Rediprime II Random Prime Labelling
166System (Amersham, UK). Hybridization was performed at 65 C
167overnight in a buffer containing 250 mM NaCl, 7% SDS and 125 mM
168phosphate, pH 7.0. After hybridization, the blot was washed twice at
169room temperature in 2 SSC plus 0.5% SDS, then at 65 C for 15 min
170in 0.2 SSC plus 0.1% SDS. The blot was analyzed using a phospho-
171imager.
1722.5. Transfection of mammalian cells followed by infection with
173influenza virus
174Confluent Madin–Darby canine kidney (MDCK) cells grown in a T-
175175 flask were washed twice with phosphate-buffered saline (PBS) and
176trypsinized for 10 min in 10 ml trypsin solution at 37 C. After ter-
ATG
ATG
A(n) 880 nt
400 nt
5mNS1 (400 nt)
Cap
CaMV 35S I - TGA1 Tnoss- 5mNS1 as- 5mNS1
A
B
C
NS1 mRNA (890 nt)
Fig. 1. The 5mNS1 sequence and the hairpin RNA construct used in producing 5mNS1 siRNAs in tobacco. (A) Schematic representation of NS1
mRNA. The cap and poly(A) tail structures are shown, and location of the 0.4-kb 5mNS1 fragment beginning from the first codon (atg) is indicated.
(B) cDNA sequence of the 5mNS, with the sequence of the synthetic siRNA NS-128 used by Ge et al. [8] underlined. (C) Diagram showing RNAi
cassette in a binary vector. The sense (S) and antisense (AS) 5mNS1 fragments are separated by the Arabidopsis TGA1 intron (I-TGA1), and are under
the control of the CaMV 35S promoter.
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177 mination of trypsinization with 20 ml PBS, the cells were collected by
178 centrifugation for 5 min at 15 000 rpm, and were washed twice in 30 ml
179 cold PBS, followed by one wash in 30 ml cold RPMI1640 medium
180 (Gibco), before resuspension in cold RPMI1640 to a density of 1 107
181 cells/ml. Subsequently, 500 ll of resuspended cells was transferred into
182 a 0.4 cm pre-chilled cuvette, and was mixed with 10 ll water, 10 ll
183 water with 42 ng NS-128, 10 ll wild-type RNA sample or 10 ll RNA
184 sample containing 42 ng siRNAs from transgenic plant. Equal
185 amounts of total RNA from wild-type or transgenic plants were used.
186 The cuvette was kept on ice for 10 min, before electroporation at 0.4
187 kV and 960 lF using a gene pulser system (Bio-Rad). Cells were then
188 transferred into 5.6 ml of pre-warmed MDCK medium (MEM, 10%
189 cow serum, 1% penicillin and 1% streptomycin). Three milliliters was
190 transferred into a 6-well plate and incubated at 37 C for 24 h before
191 infection with the influenza virus.
192 2.6. Virus infection and hemagglutination (HA) titer test
193 Twenty-four hours after transfection, cells in each well were washed
194 twice with PBS, and 300 ll diluted influenza virus strain A/WSN/33
195 (MOI¼ 0.001 in PBS) was added into the well. After shaking the
196 mixture for 1 h, the viruses in the supernatant were discarded, and 2 ml
197 infection medium [0.5 lg/ml TPCK-trypsin (Sigma), 0.5% FCS (Gib-
198 co), and 1% PS with MEM (Gibco)] was added into the well. The cells
199 were then incubated at 37 C. Supernatants were collected at different
200 post-infection time points for the HA titer test as described [8].
201 3. Results and discussion
202 Influenza A viruses are medically important viral pathogens
203 that cause significant mortality and morbidity throughout the
204 world. Their easy transmission, antigenic shift and drift have
205 made current methodology of vaccination and therapy limited
206 in efficacy [22]. Inhibitors of the anti-M2 ion channel and
207 neuraminidase are common drugs for influenza, but both have
208 their drawbacks. The anti-M2 ion channel inhibitors (e.g.,
209 amantidine) induce viruses to develop drug-resistant muta-
210 tions, while the neuraminidase inhibitors (e.g., Tamiflu),
211 though very potent, are effective only at early disease onset. To
212 investigate if plant-derived siRNAs against the influenza virus
213 could inhibit viral replication, we selected a 0.4-kb fragment
214 representing the 50-portion of the NS1 gene in strain A/WSN/
215 33, subtype H1N1. The NS virion RNA (vRNA) consists of
216 about 890 nucleotides and encodes two non-structural pro-
217 teins, NS1 and NS2. The sequence of this vRNA is highly
218 conserved among different subtypes of influenza viruses [23].
219 The NS1 protein has not only been proposed to regulate viral
220 replication cycle, splicing and translation of mRNAs [24], but
221 also been shown to have inhibitory effect on cellular mRNA
222 maturation and cellular anti-viral response [25]. Thus, the NS1
223 gene plays an important role in virus replication and virus–
224 host interactions. The chosen 0.4-kb fragment was amplified
225 by PCR, and then sequentially cloned in sense and antisense
226 orientations, on either side of the Arabidopsis TGA1 intron.
227 The resulting cassette of ‘‘sense–intron–antisense’’ was ex-
228 pressed from the CaMV 35S promoter in a binary vector
229 (Fig. 1C). Hence, transgenic plants obtained in Agrobacterium-
230 mediated plant transformation from this binary vector should
231 produce hairpin dsRNA, which would subsequently be pro-
232 cessed into siRNAs by the PTGS machinery.
233 Reports have shown that ‘‘sense–antisense’’ cassettes can be
234 transcribed to produce siRNAs after transfection of host cells
235 [11,26,27]. To investigate if the construct generated in this
236 study (Fig. 1C) could produce siRNA in transgenic tobacco,
237 RNAs from leaves of primary transformants was separated on
238 a gel of 15% polyacrylamide and 7 M urea, blotted onto ni-
239trocellulose membrane and hybridized to [32P]UTP-labeled
2405mNS1 riboprobes. Of 21 independent transformants
241screened, 13 showed obvious siRNA production. The levels of
242siRNA accumulation in different lines varied, some produced
243obvious signals after an overnight exposure using a phospho-
244imager, while others barely yielded visible signals (data not
245shown). The siRNA signals in selected transgenic lines are
246shown in Fig. 2. Transgenic lines 1 and 2 had apparent accu-
247mulation of 5mNS1 siRNAs, while lines 8 and 9 produced
248much lower levels of the same siRNAs. In line 10, the siRNAs
249were barely detectable.
250A variation in siRNA levels may be due to several reasons.
251First, T-DNA location in the genome could affect expression.
252In Agrobacterium-mediated plant transformation, T-DNA is
253transferred from the bacterium to the eukaryotic host cell and
254further integrated into the host genome [28]. If the transgene
255were inserted in the genome where active transcription occurs,
256the transgene would be active. Otherwise, it would be less
257active or even silent. Second, the copy number of the transgene
258may be a contributing factor in expression levels, although in
259some cases, transgene activity may not be directly proportional
260to its copy number due to co-suppression. Third, methylation
261of transgene may occur, especially at or near promoter if it is
262considered foreign. As a safeguard, the host generally has a
263mechanism to methylate and inactivate the transgene. This has
264been reported with foreign DNA expressing dsRNA in PTGS
265[29,30] and is supported by a requirement of DNA methylase
266in initiating RNA-dependent DNA methylation [31].
267As revealed by an increasing number of reports, siRNA is
268the hallmark in triggering RNAi. Therefore, the accumulated
2695mNS1 siRNAs in the transgenic plants should initiate deg-
270radation of NS1 transcripts or endogenous tobacco transcripts
271with sequences complementary to 5mNS1. A BLAST analysis
272was performed with 5mNS1 as query sequence for such com-
273plementation in transcripts of tobacco or species evolutionarily
274close to tobacco, but no match was identified. Northern blot
275analysis of tobacco total RNA with the 5mNS1 probe also did
276not yield any obvious bands. Therefore, 5mNS1 does not seem
277to share homology to any tobacco transcripts and would not
278cause unintended degradation of RNA transcribed from en-
279dogenous genes. This is consistent with the fact that no ab-
280normal phenotypes were observed in all the transgenic lines
Fig. 2. Accumulation of the 5mNS1 siRNA in selected primary
transformants and in wild-type tobacco (WT). (A) Twenty micrograms
of total RNA from leaves of transgenic tobacco was separated on a
15% polyacrylamide gel containing 7 M urea, blotted and hybridized
to [32P]UTP-labeled 5mNS1 riboprobes. (B) Normalization of RNA
loading was based on the separation of 6 lg of total RNA on a 1.2%
agarose gel.
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281 (data not shown). To test if the plant-derived 5mNS1 siRNAs
282 were functional in degrading NS1 transcripts specifically,
283 5mNS1- and EYFP-T2m-expressing binary vectors were in-
284 troduced into Agrobacterium cells which were used to co-in-
285 filtrate leaves of wild-type tobacco and those of transgenic
286 tobacco lines expressing 5mNS1 siRNAs. As shown in Fig. 3B,
287 all the three transgenic lines 1, 9 and 19, representing high,
288 middle and low accumulation of 5mNS1 siRNA, respectively,
289 had reduced 5mNS1 RNA levels, indicating that plant-derived
290 5mNS1 siRNAs indeed triggered PTGS of NS1 in vivo. A
291 negative correlation was observed between the levels of 5mNS1
292 siRNAs and 5mNS1 transcripts in infiltrated tobacco leaves.
293 To obtain a percentage of the 5mNS1 transcript level in the
294transgenic lines relative to that of wild-type, volumes of each
2955mNS1 band and of the reference EYFP band were determined
296using the ImageQuant software, and percentage was calculated
297using the formula described in Fig. 3 legend. In transgenic
298tobacco line 1, which had the highest level of 5mNS1 siRNA
299accumulation, the percentage was only 0.4%, demonstrating
300high efficiency of this line in 5mNS1-specific RNA degradation
301(Fig. 3C).
302In RNAi studies, synthetic or in vitro expressed siRNAs
303have been used in transfection of target cells [26], and injection
304of worms [32] and animals [33], for evaluation of siRNA effi-
305cacy. To test if the 5mNS1 siRNAs produced in transgenic
306tobacco could be potentially used in suppressing viral propa-
Fig. 3. Suppression of 5mNS1 transcript accumulation in siRNA-expressing lines. Wild-type tobacco and transgenic plants expressing different levels
of 5mNS1 siRNAs were co-infiltrated with two binary vectors separately expressing 5mNS1 and a fusion fragment of EYFP T2m. After two days, leaf
samples were collected for RNA analysis by Northern blot analysis. (A) Part of the T-DNA in the two binary vectors. (B) Northern blot analysis
showing levels of EYFP-T2m and 5mNS1 transcripts in the different infiltrated samples. The 28S rRNA was stained with ethidium bromide. The
5mNS1 levels are lowered in transgenic plants when compared to levels in WT. (C) The 5mNS1 transcript level, as a percentage of the wild-type, was
calculated with data from three separate infiltrations. Calculation was performed according to the formula of:
5mNS1 level ð% of WTÞ ¼ ð100Þ  ð5 mNS1 volume of transgenic lineÞ  ðEYFP volume of wild-typeÞð5mNS1 volume of wild typeÞ  ðEYFP volume of transgenic lineÞ :
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307 gation in mammalian cells infected with the influenza virus,
308 5mNS1 siRNAs were harvested from the leaves of transgenic
309 plants for transfection of MDCK cells. The amount of siRNA
310 in total RNA was quantified by siRNA analysis (Fig. 4A). As a
311 positive control, we used siRNA oligo NS-128 (50-
312 CGGCUUCGCCGAGAUCAGAdAdT-30), since it has been
313 proven best of three NS1-targeting siRNA oligos [8]. Cells
314 transfected with RNA from non-transformed plants were the
315 negative control and cells transfected with water constituted
316 the mock transfection. Twelve hours after transfection, cells
317 were infected by the influenza virus strain A/WSN/33
318 (MOI¼ 0.001). The HA titer, which is an indicator of viral
319 replication, was determined at 12, 24 and 36 h post-infection.
320 The mock-transfected and the negative control cells showed
321 similar HA titer, indicating that RNA from wild-type tobacco
322 plants did not suppress viral replication. Though the HA titer
323 values varied in three separate sets of transfection and infec-
324 tion studies, a phenomenon unavoidably associated with
325 conditions of the cells, e.g., passage history, both plant-derived
326 and synthetic siRNAs significantly reduced H1N1 viral repli-
327 cation. The anti-viral effect of siRNA was most prominent at
328 36 h post-infection (Fig. 4B). In one set of experiments, plant-
329 derived siRNA proved superior to the NS-128 oligo (Fig. 4B,
330 experiment A).
331 These results strongly support our hypothesis that 5mNS1
332 siRNA from transgenic plants can effectively suppress repli-
333cation of the influenza virus in mammalian cells. In addition,
334plant siRNAs showed similar suppression ability as the syn-
335thetic siRNA NS-128, demonstrating that plant-derived siR-
336NAs confer the same efficacy. Given the fact that transgenic
337plants can generate siRNAs targeting different areas of the
3385mNS1 transcript, and that NS1 sequences are highly con-
339served among influenza viruses [23], 5mNS1 siRNAs from
340transgenic plants should suppress the replication of a broad
341range of influenza viral subtypes with sequences homologous
342to the 5mNS1.
343While our results clearly indicate anti-viral effects of plant-
344derived 5mNS1 siRNAs, this study is primarily focusing on
345developing a strategy for economical and sustainable produc-
346tion of siRNAs. Besides using transgenic technology described
347in this study, a pool of siRNAs can also be generated with
348Dicer-dependent kits. When compared with the transgenic
349approach, the latter method is much more expensive, since it
350involves expensive reagents (i.e., dNTP, Dicer, and RNA
351polymerase), complicated steps (i.e., in vitro transcription, in
352vitro cleavage of dsRNA, and clean-up) and experienced re-
353searcher. The high cost not only limits production scale, but
354also requires repetition of the production process if the siR-
355NAs are to be used over and over again. Therefore, our proof-
356of-concept study demonstrates that transgenic plants are su-
357perior to the commercial kits for siRNA production and the
358time taken for generating them would be well compensated.
Fig. 4. Plant-derived 5mNS1 siRNAs can suppress replication of the influenza virus A/WSN/33 in mammalian cells. (A) Total RNA (10 lg) from
primary transformants 1 and 2 was separated on a 15% polyacrylamide gel, blotted onto a Nylon membrane and probed with [32P]UTP-labeled
5mNS1 RNA probes. Quantity of siRNAs in the RNA samples was calculated based on its relative volume to that of known amount of synthetic
siRNA oligo. These RNA preparations were then used for transfection of MDCK cells. (B) Normalization of RNA loading was based on the
separation of 6 lg of total RNA on a 1.2% agarose gel. (C) Suppression of viral replication as revealed in three independent HA titer assays. MDCK
cells were first transfected with water (mock), a siRNA oligo NS-128 used by Ge et al. [8], and RNA from wild-type tobacco (control) or from two
transgenic lines (line 1 and line 2) expressing siRNAs, and were then infected by influenza virus strain A/WSN/33 24 h post-transfection. HA titer was
determined at 24 (blue boxes), 36 (red boxes) and 48 h (yellow boxes) post-infection.
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359 Though the NS1-targeting siRNAs possess anti-viral effects,
360 those against the NP genes would be more potent in sup-
361 pressing viral replication, as revealed by studies using mam-
362 malian cells [8] and animals [34]. In both studies, one of the
363 NP-targeting siRNAs, Np-1496, significantly reduced the virus
364 titers. These observations indicate that mRNA of the NP gene
365 might be a better target of siRNA, if positional effects on
366 siRNA accessibility could be faithfully addressed. In our fu-
367 ture study of using transgenic plant-derived siRNAs for viral
368 suppression, generating NP-targeting siRNAs would be a
369 more practical practice.
370 In conclusion, 5mNS1 siRNAs capable of activating RNAi
371 in mammalian cells against NS1 were produced in transgenic
372 tobacco plants. The efficacy of the plant-derived siRNAs was
373 tested in vivo by agroinfiltration of the 5mNS1-expressing
374 construct in leaves of transgenic tobacco and in vitro by ap-
375 plication of these siRNAs in mammalian cells to inhibit in-
376 fluenza viral replication. This cost-effective technique in
377 utilizing transgenic plants for large-scale siRNA production
378 could have advantages over current methods involving the use
379 of synthetic RNA oligos, the expression of short hairpin RNA
380 in Escherichia coli [35,36] and the transfection of mammalian
381 cells with short dsRNA. In addition, plant cells can apparently
382 tolerate expression of long dsRNAs, enabling the length of the
383 target gene fragment to be easily manipulated for optimal
384 suppression. Moreover, fragments producing siRNAs target-
385 ing multiple sites of the viral genome can be fused together so
386 that one transgenic plant can produce siRNAs for simulta-
387 neous silencing of multiple genes. This could provide a more
388 robust and sustained viral protection minimizing the likeli-
389 hood of the virus developing resistance to the siRNA through
390 mutation of the target sequence.
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